IPO
-
-
-
-
-
-
-
Elanco (ELAN) Announces Corporate Governance Enhancements
-
-
-
-
-
-
-
Elanco Announces Next Wave of Restructuring to Drive Operational Efficiencies Post Bayer Acquisition
-
-
-
-
-
-
-
Elanco Animal Health Reports Third Quarter Results
-
-
-
-
-
-
-
Elanco Animal Health to File Registration Statement in Connection With Lilly Divestiture Announcement
-
-
-
-
-
-
-
Lilly Announces Financial Guidance, Reviews Commercial Performance, and Highlights Promising Pipeline Opportunities at Investment Community Meeting
-
-
-
-
-
-
-
Elanco Announces Full Exercise of Additional Stock, Sets Date for Q3 Earnings
-
-
-
-
-
-
-
Lilly's (LLY) Subsidiary Elanco Animal Health's (ELAN) IPO Prices at $24/Share
-
122,327 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

